This indicates that the oncogenic effects of hypoxia are at least partially mediated by TRIM21 downregulation, and underscores TRIM21 as a key modulator of hypoxia-adaptive tumor behavior via post-translational control of ID1. The gene discussed is ID1; the disease is neoplasm.